A new and more effective feticide technique in late termination of pregnancy: potassium chloride injection into the interventricular septum of the fetal heart.

Feticide Interventricular septal injection Late termination of pregnancy Potassium chloride

Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
03 2023
Historique:
received: 25 07 2022
accepted: 12 09 2022
pubmed: 23 10 2022
medline: 8 3 2023
entrez: 22 10 2022
Statut: ppublish

Résumé

This study sought to compare the efficacy and outcomes of fetal intracardiac intraventricular and interventricular septal potassium chloride (KCl) injections during the induced fetal demise process in a cohort of pregnant women with severe fetal abnormality who opted for late termination of pregnancy (TOP). This study consisted of 158 pregnant women who requested late TOP for severe fetal abnormality between 22 and 36 weeks of pregnancy. Participants were randomly assigned with the simple randomization procedure to one of two feticide procedure groups: the intraventricular KCl injection group and the interventricular septal KCl administration group. We studied the clinical outcomes of both the feticide procedures. The median total dose of strong KCl was significantly lower in the interventricular septal KCl administration group (3 mL) than in the intraventricular KCl injection group (5 mL, p < 0.001). The median time to reach asystole and the median total duration of the procedure was significantly shorter in the interventricular septal KCl administration group (42 s and 85 s, respectively) than in the intraventricular KCl injection group (115 s and 150 s, respectively, p < 0.001). We detected a statistically significant correlation between the gestational week at feticide and the total dose of KCl (r = 0.705, p < 0.001), time to reach asystole (r = 0.653, p < 0.001), and total duration of the procedure (r = 0.683, p < 0.001). KCl administered directly into the interventricular septum induces immediate and permanent fetal cardiac asystole with a 100% of success rate without comprising maternal safety. We did not observe any maternal complications related to the procedure in our cases. Since the consequences of failed feticide procedure are challenging for both parents and healthcare providers, and providers are also concerned about potential legal implications regarding an unintended live birth, it is crucial to guide a strict protocol to confirm permanent fetal cardiac asystole.

Identifiants

pubmed: 36271257
doi: 10.1007/s00404-022-06795-8
pii: 10.1007/s00404-022-06795-8
doi:

Substances chimiques

Potassium Chloride 660YQ98I10

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

779-787

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Phadke SR, Agarwal M, Aggarwal S (2011) Late termination of pregnancy for fetal abnormalities: the perspective of Indian lay persons and medical practitioners. Prenat Diagn 31(13):1286–1291. https://doi.org/10.1002/pd.2887
doi: 10.1002/pd.2887 pubmed: 22030841
Rydberg C, Tunón K (2017) Detection of fetal abnormalities by second-trimester ultrasound screening in a non-selected population. Acta Obstet Gynecol Scand 96(2):176–182. https://doi.org/10.1111/aogs.13037
doi: 10.1111/aogs.13037 pubmed: 27714775
Pasquini L, Pontello V, Kumar S (2008) Intracardiac injection of potassium chloride as method for feticide: experience from a single UK tertiary centre. BJOG 115(4):528–531. https://doi.org/10.1111/j.1471-0528.2007.01639.x
doi: 10.1111/j.1471-0528.2007.01639.x pubmed: 18271890
Breeze AC, Lees CC, Kumar A, Missfelder-Lobos HH, Murdoch EM (2007) Palliative care for prenatally diagnosed lethal fetal abnormality. Arch Dis Child Fetal Neonatal Ed 92(1):F56–F58. https://doi.org/10.1136/adc.2005.092122
doi: 10.1136/adc.2005.092122 pubmed: 16705007
Senat MV, Fischer C, Bernard JP, Ville Y (2003) The use of lidocaine for fetocide in late termination of pregnancy. BJOG 110(3):296–300
doi: 10.1046/j.1471-0528.2003.02217.x pubmed: 12628271
Govender L, Moodley J (2012) Late termination of pregnancy by intracardiac potassium chloride injection: 5 years’ experience at a tertiary referral centre. S Afr Med J 103(1):47–51. https://doi.org/10.7196/samj.6006
doi: 10.7196/samj.6006 pubmed: 23237125
RCOG (2004) The care of women requesting induced abortion guidelines No. 7. Royal college of obstetricians and gynaecologists [Evidence Grade: III], London
Diedrich J, Drey E, Society of Family Planning (2010) Induction of fetal demise before abortion. Contraception 81(6):462–473. https://doi.org/10.1016/j.contraception.2010.01.018
doi: 10.1016/j.contraception.2010.01.018 pubmed: 20472112
Sharvit M, Klein Z, Silber M, Pomeranz M, Agizim R, Schonman R, Fishman A (2019) Intra-amniotic digoxin for feticide between 21 and 30 weeks of gestation: a prospective study. BJOG 126(7):885–889. https://doi.org/10.1111/1471-0528.15640
doi: 10.1111/1471-0528.15640 pubmed: 30703286
Tufa TH, Prager S, Lavelanet AF, Kim C (2020) Drugs used to induce fetal demise prior to abortion: a systematic review. Contracept X 2:100046. https://doi.org/10.1016/j.conx.2020.100046
doi: 10.1016/j.conx.2020.100046 pubmed: 33294839 pmcid: 7689273
Sfakianaki AK, Davis KJ, Copel JA, Stanwood NL, Lipkind HS (2014) Potassium chloride-induced fetal demise: a retrospective cohort study of efficacy and safety. J Ultrasound Med 33(2):337–341. https://doi.org/10.7863/ultra.33.2.337
doi: 10.7863/ultra.33.2.337 pubmed: 24449738
Oğlak SC, Bademkıran MH, Obut M (2020) Predictor variables in the success of slow-release dinoprostone used for cervical ripening in intrauterine growth restriction pregnancies. J Gynecol Obstet Hum Reprod 49(6):101739. https://doi.org/10.1016/j.jogoh.2020
doi: 10.1016/j.jogoh.2020 pubmed: 32251738
Corbacıoğlu A, Aslan H, Aydın S, Akbayır O, Ersan F, Alpay V et al (2012) Trends in fetal indications for termination of pregnancy between 2002 and 2010 at a tertiary referral centre. J Turk Ger Gynecol Assoc 13(2):85–90. https://doi.org/10.5152/jtgga.2012.09
doi: 10.5152/jtgga.2012.09 pubmed: 24592014 pmcid: 3939143
Napolitano R, Thilaganathan B (2010) Late termination of pregnancy and foetal reduction for foetal anomaly. Best Pract Res Clin Obstet Gynaecol 24(4):529–537. https://doi.org/10.1016/j.bpobgyn.2010.02.004
doi: 10.1016/j.bpobgyn.2010.02.004 pubmed: 20350838
Jackson RA, Teplin VL, Drey EA, Thomas LJ, Darney PD (2001) Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial. Obstet Gynecol 97(3):471–476. https://doi.org/10.1016/s0029-7844(00)01148-0
doi: 10.1016/s0029-7844(00)01148-0 pubmed: 11239659
Gill P, Cyr D, Afrakhtah M, Mack L, Easterling T (1994) Induction of fetal demise in advanced pregnancy terminations: report on a funic potassium chloride protocol. Fetal Diagn Ther 9(4):278–282. https://doi.org/10.1159/000263948
doi: 10.1159/000263948 pubmed: 7945911
Bhide A, Sairam S, Hollis B, Thilaganathan B (2002) Comparison of feticide carried out by cordocentesis versus cardiac puncture. Ultrasound Obstet Gynecol 20(3):230–232. https://doi.org/10.1046/j.1469-0705.2002.00797.x
doi: 10.1046/j.1469-0705.2002.00797.x pubmed: 12230443
Stephenson RS, Atkinson A, Kottas P, Perde F, Jafarzadeh F, Bateman M et al (2017) High resolution 3-dimensional imaging of the human cardiac conduction system from microanatomy to mathematical modeling. Sci Rep 7(1):7188. https://doi.org/10.1038/s41598-017-07694-8
doi: 10.1038/s41598-017-07694-8 pubmed: 28775383 pmcid: 5543124
Isada NB, Pryde PG, Johnson MP, Hallak M, Blessed WB, Evans MI (1992) Fetal intracardiac potassium chloride injection to avoid the hopeless resuscitation of an abnormal abortus: I. Clinical issues. Obstet Gynecol 80(2):296–299
pubmed: 1635748
Lee SJ, Ralston HJ, Drey EA, Partridge JC, Rosen MA (2005) Fetal pain: a systematic multidisciplinary review of the evidence. JAMA 294(8):947–954
doi: 10.1001/jama.294.8.947 pubmed: 16118385
Norton ME, Cassidy A, Ralston SJ, Chatterjee D, Farmer D, Beasley AD et al (2021) Society for maternal-fetal medicine consult series #59: the use of analgesia and anesthesia for maternal-fetal procedures. Am J Obstet Gynecol 225(6):B2–B8
doi: 10.1016/j.ajog.2021.08.031 pubmed: 34507800 pmcid: 8763622
Schwarz U, Galinkin JL (2003) Anesthesia for fetal surgery. Semin Pediatr Surg 12(3):196–201
doi: 10.1016/S1055-8586(03)00025-8 pubmed: 12961114

Auteurs

Sema Süzen Çaypınar (S)

Department of Perinatology, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey.

Süleyman Cemil Oğlak (SC)

Department of Obstetrics and Gynecology, Gazi Yaşargil Training and Research Hospital, Health Sciences University, Diyarbakır, Turkey. sampson_21@hotmail.com.

İbrahim Polat (İ)

Department of Perinatology, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey.

Kübra Kurt Bilirer (K)

Department of Perinatology, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey.

Salim Sezer (S)

Department of Perinatology, Esenyurt University Hospital, Istanbul, Turkey.

Zeynep Gedik Özköse (Z)

Department of Perinatology, Kanuni Sultan Süleyman Training and Research Hospital, Health Sciences University, Istanbul, Turkey.

Sema Karakaş (S)

Department of Gynecologic Oncology, Bakırköy Dr Sadi Konuk Training and Research Hospital, Health Sciences University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH